Deal Library / Pharma BD Deal Intelligence

Pharma Deals of 2003

The Pharma Closeout tracks 23 deals, $108.5B in disclosed deal value, 22 with a post-close Outcome Score for the year 2003.

Median Critic Score: 75  ·  Median Outcome Score: 68

Best outcome: Eli Lilly and Company / Applied Molecular Evolution Inc. (88)  ·  Weakest outcome: Pfizer Inc. / Esperion Therapeutics Inc. (12)

All 23 deals

• Eli Lilly and Company / Applied Molecular Evolution Inc. — 2003 · $400M · Worked — the deal delivered on its rationale.
• Takeda Pharmaceutical Company Ltd. / Millennium Pharmaceuticals — 2003 · $8.8B · Worked — the deal delivered on its rationale.
• Genzyme Corporation / SangStat Medical Corporation — 2003 · $600M · Worked — the deal delivered on its rationale.
• Takeda Pharmaceutical Company Ltd. / Ariad Pharmaceuticals — 2003 · $5.2B · Worked — the deal delivered on its rationale.
• IDEC Pharmaceuticals Corporation / Biogen Inc. — 2003 · $6.5B · Worked — the deal delivered on its rationale.
• Johnson & Johnson / Crucell NV — 2003 · $2.4B · Worked — the deal delivered on its rationale.
• Cardinal Health Inc. / Syncor International Corporation — 2003 · $760M · Largely worked — most objectives met.
• Inverness Medical Innovations Inc. / Abbott Laboratories Rapid Diagnostics (pregnancy / drug-of-abuse lines) — 2003 · $92M · Largely worked — most objectives met.
• Johnson & Johnson / Abbott Medical Optics — 2003 · $4.3B · Largely worked — most objectives met.
• Watson Pharmaceuticals Inc. / Amarin Development AB (Amarin Corp subsidiary) — 2003 · $150M · Largely worked — most objectives met.
• GSK plc / Bellus Health Inc. — 2003 · $2.0B · Largely worked — most objectives met.
• Roche Holding AG / IGEN International Inc. — 2003 · $1.4B · Largely worked — most objectives met.
• Teva Pharmaceutical Industries Ltd. / Sicor Inc. — 2003 · $3.4B · Largely worked — most objectives met.
• Cadbury Schweppes plc / Adams Confectionery (Pfizer division) — 2003 · $4.2B · Largely worked — most objectives met.
• Merck & Co. Inc. / Banyu Pharmaceutical Co. Ltd. — 2003 · $1.5B · Largely worked — most objectives met.
• Novartis AG / Mead Johnson Adult Medical Nutrition (BMS divestiture) — 2003 · $385M · Largely worked — most objectives met.
• Zimmer Holdings Inc. / Centerpulse AG — 2003 · $3.2B · Largely worked — most objectives met.
• Pfizer Inc. / Pharmacia Corporation — 2003 · $60.0B · Largely worked — most objectives met.
• Cephalon Inc. / CIMA Labs Inc. — 2003 · $515M · Mixed — partial payoff, real shortfalls.
• Roche Holding AG / Disetronic Holding AG — 2003 · $1.2B · Did not work — the deal failed to deliver.
• Endo Pharmaceuticals Inc. / SkyePharma plc — 2003 · $120M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Esperion Therapeutics Inc. — 2003 · $1.3B · Did not work — the deal failed to deliver.
• Barr Pharmaceuticals Inc. / Endeavor Pharmaceuticals — 2003 · $35M

← Deal Library  ·  Interactive search  ·  How we score deals